Singapore’s Cordlife buys back S$47 million of 4.9% notes due 2017

By Susanna Moon

Chicago, Dec. 16 – Cordlife Group Ltd. said it repurchased S$47 million principal amount of its 4.9% notes due 2017.

After settlement on Dec. 18, the outstanding amount of notes will be S$73 million, according to a company notice.

Cordlife said it issued S$120 million principal amount of the notes on Oct. 29, 2014 under its S$500 million multicurrency debt issuance program.

Cordlife is a Singapore-based health care company that provides cord blood and cord lining banking services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.